COST vs MYGN · P/E 55, rev $275.24B vs rev $837.6M
Costco Wholesale Corp (COST) versus Myriad Genetics Inc (MYGN) — a side-by-side from cached financials, not a winner call.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron M. Vachris.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
COST currently screens at market cap $430.32B and trailing P/E 54.9. MYGN currently screens at market cap $413.7M.
Not investment advice. Open the COST and MYGN stock pages for the full models.
Not investment advice.